Rob_Dow.jpg

Robert J. Dow, BSC, MBCHB, FRCP (EDIN), FFPM

Senior Vice President and Chief Medical Officer, PPD

Dr. Dow currently serves as Senior Vice President and Chief Medical Officer of PPD.  In this role, he leads three functions. The Global Product Development organization provides medical, scientific and product development expertise to PPD clients and internal operational and business development teams. The group has substantial expertise in all major therapeutic areas. The Global Consulting group, a team of twenty four regulatory experts and product development team leaders, provide drug development, asset management and regulatory strategic consulting to PPD’s clients. The Strategic Client Solutions Group, a team of industry professionals with business development and financial backgrounds provide strategic capability focused on the development of new or existing service offerings and generation of evidence which substantiates PPD’s differentiated position in the market.

Dr. Dow has prior experience in the following management roles- Chief Executive Officer (Scotia PLC and Biolitec Pharma), Chief Medical Officer (Cell Genesys Inc), Global Head of Development (Hoffman la Roche) , and non-executive Board Member (Oxford Assymetry).

Dr. Dow received his Bachelor’s degree in Medical Sciences from St. Andrews University, his Bachelor of Medicine and Surgery from the University of Dundee and his MRCP(UK) Diploma and Specialty Certificate from the Royal College of Physicians (UK). Additionally, he is a Fellow of the Royal College of Physicians of Edinburgh and a Fellow of the Faculty of Pharmaceutical Medicine of the Royal College of Physicians of the United Kingdom.